AskNiveshWeekend·19:34 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to STAR

STRIDES PHARMA SCIENCE LIMITED: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,1901,1201,2211,1951,323
Other income
129271078
Expenses
1,0729981,0851,0531,179
Cost of materials consumed
270261430460409
Purchases of stock-in-trade
2321214271127
Change in inventories
-26344-68-0.10
Employee benefit expense
223226227230247
Finance costs
5048464342
Depreciation & amortisation
4949505153
Other expenses
251232247266300
EBITDA
202218250340242
EBIT
153170200289189
Exceptional items
-27-8-9-3-6
Profit Before Tax
103122154246147
Tax expense
2116223719
Deferred tax
166-1102
Net Profit
86106132208129
Financial Ratios
Operating Profit Margin
12.88%15.13%16.39%24.22%14.26%
EBITDA Margin
16.99%19.50%20.45%28.45%18.28%
Net Profit Margin
7.19%9.46%10.81%17.41%9.75%
Earnings Per Share (₹)
8.9210.8113.8421.9313.77

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.